Risk evaluation and monitoring in multiple sclerosis therapeutics. Clanet MC, Wolinsky JS, Ashton RJ, Hartung H-P, Reingold SC Mult Scler. 2013 Nov 30. PMID: 24293456. Abstract CommentRecommendBookmarkWatch